Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.85 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.56 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.40 |
| ▸ | LSS | P48449 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29076360 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL133028 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL7733446 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL7733130 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL133404 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25394046 | 1.00 | CYP1A2 (0.85) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25391848 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25392743 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25391637 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA | |
| SCHEMBL25393174 | 0.97 | CYP1A2 (0.81) | CYP1A2SIGMAR1EPHX1ALDH1A1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441901-B2 | Quantum dot ink composition, and quantum dot electroluminescent device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-14 | — | — | US | disclosed |
| US-20240182471-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2024-06-06 | — | — | US | disclosed |
| CN-117897468-A | Production of monoaromatics from hydrocarbon feedstocks | 沙特基础工业全球技术有限公司 | 2024-04-16 | — | — | CN | disclosed |
| US-11912704-B2 | Methods and compositions for substituted arylcycloheptane analogs | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-11912704-B2 | Methods and compositions for substituted arylcycloheptane analogs | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20230287231-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| CN-116606568-A | Quantum dot ink composition and quantum dot electroluminescent device | 三星电子株式会社 | 2023-08-18 | — | — | CN | disclosed |
| US-20230257607-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-17 | — | — | US | disclosed |
| US-20210300928-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-09-30 | — | — | US | disclosed |
| WO-2020033567-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION (US) | 2020-02-13 | — | — | WO | disclosed |
| US-5755833-A | URETHANE COMPOUND; ANTIDEPOSIT, ANTISLUDGING AGENT; GASOLINE | NIPPON OIL CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0819753-A1 | Fuel additive | NIPPON OIL CO. LTD. (JP) | 1998-01-21 | — | — | EP | disclosed |
| EP-0801128-A1 | Fuel additive | NIPPON OIL CO. LTD. (JP) | 1997-10-15 | — | — | EP | disclosed |
| EP-0723985-A1 | Fuel additive | NIPPON OIL CO. LTD. (JP) | 1996-07-31 | — | — | EP | disclosed |
| US-5155268-A | Antiarrhythmic N-aminoalkylene alkyl and aryl sulfonamides | THE UPJOHN COMPANY (US) | 1992-10-13 | — | — | US | disclosed |
| EP-0164865-B1 | N-(AMINOALKYLPHENYL)SULFONAMIDES THEIR PREPARATION AND THERAPEUTIC USE | THE UPJOHN COMPANY (US) | 1988-12-21 | — | — | EP | disclosed |
| EP-0164865-A1 | N-(Aminoalkylphenyl)sulfonamides their preparation and therapeutic use | THE UPJOHN COMPANY (US) | 1985-12-18 | — | — | EP | disclosed |
| US-4352938-A | ADHESION OF POLYPROPYLENE TO GLASS FIBERS OR TIRE CORDS TO RUBBER | HERCULES INCORPORATED (US) | 1982-10-05 | — | — | US | disclosed |
| US-4240971-A | USED TO MODIFY AND CROSSLINK POLYMERS AND AS A BONDING AGENT | HERCULES INCORPORATED (US) | 1980-12-23 | — | — | US | disclosed |
| US-3992451-A | IN THE PRESENCE OF FREE RADICAL CATALYSTS, HYDROGEN CHLORIDE, AND CARBON MONOXIDE | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210300928-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS | AHR, HCCS, HMBS | CYP1A2 25/4885SIGMAR1 1822/4885EPHX1 485/4885 |
| US-20240182471-A1 | METHODS AND COMPOSITIONS FOR SUBSTITUTED ARYLCYCLOHEPTANE ANALOGS | AHR, HCCS, HMBS | CYP1A2 25/4885SIGMAR1 1822/4885EPHX1 485/4885 |
| US-11912704-B2 | Methods and compositions for substituted arylcycloheptane analogs | AHR, HCCS, HMBS | CYP1A2 25/4885SIGMAR1 1822/4885EPHX1 485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.